1-3 of 3
R. Delarue
Close
Sort by
Journal Articles

FDG-PET–driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study

Clinical Trials & Observations
R.-O. Casasnovas, L. Ysebaert, C. Thieblemont, E. Bachy, P. Feugier, A. Delmer, S. Tricot, J. Gabarre, M. Andre, C. Fruchart, N. Mounier, R. Delarue, M. Meignan, A. Berriolo-Riedinger, S. Bardet, J.-F. Emile, J.-P. Jais, C. Haioun, H. Tilly, F. Morschhauser
Journal: Blood
Blood (2017) 130 (11): 1315–1326.
https://doi.org/10.1182/blood-2017-02-766691
Published: 2017
Includes: Supplemental data
Journal Articles

Safety of Prophylactic Use of Darbepoetin Alfa in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP 14 or R-CHOP21: Preliminary Results of the LNH03-6B Randomized GELA Study.

R. Delarue, N. Mounier, C. Haioun, B. Coiffier, C. Gisselbrecht, H. Ghesquieres, P. Lederlin, M. Blanc, C. Recher, O. Hermine, F. Reyes, H. Tilly, A. Bosly
Journal: Blood
Blood (2006) 108 (11): 2436.
https://doi.org/10.1182/blood.V108.11.2436.2436
Published: 2006
Journal Articles

Is There a Role for ATRA in Combination to EPO in Lower Risk Myelodysplastic Syndrome? Preliminary Results of a Phase II Study.

L. Ades, H. Mohamed, D. Vassilief, E. Berger, B. Slama, N. Vey, R. Delarue, O. Beyne-Rauzy, A. Guerci, S. Cheze, X. Thomas, A. Stamatoullas, M. Gardembas, F. Bauduer, A. Kolb, M.C. Chaury, L. Legros, G. Damaj, F. Hamza, S. Vaultier, F. Dreyfus, P. Fenaux
Journal: Blood
Blood (2005) 106 (11): 2537.
https://doi.org/10.1182/blood.V106.11.2537.2537
Published: 2005